Site-specific recombinases are being developed as tools for "in vivo" genetic engineering because The lacZ target vector containing Flp recombinase target (FRT) sites (pFRTZ; Fig. 1A ) was generated by inserting the HindIII/SalI fragment from pSLh3APr-lacZ-pA (22) (27) .
Site-specific recombinases are being developed as tools for genetic engineering because of their simplicity and precise activity in a variety of organisms. Two well-studied recombinases include Flp, from Saccharomyces cerevisiae, and Cre, from bacteriophage P1; both have been shown to catalyze excisions, integrations, inversions, or translocations of DNA between their distinct recognition target sites without requiring added cofactors (1) (2) (3) (4) (5) (6) . The type of recombination reaction is determined by the orientation of target sites relative to each other on a segment of DNA; in particular, directly repeated sites specify excision of intervening DNA.
Controlled recombinase expression in an organism carrying appropriately placed target sites can be exploited to alter the genotype of subsets of cells within an otherwise normal embryo or adult. Such mosaic animals bearing clones of genetically distinct somatic cells have been most extensively generated in Drosophila using Flp, providing the means to address previously intractable problems. For example, Flpmediated excisional recombination has been used to irreversibly activate a marker gene in specific cell populations and their descendants, allowing cell lineages to be studied (7, 8) ; similarly, genes have been ectopically expressed to study their effects on pattern formation (9) . By promoting mitotic exchange between target sites on homologous Drosophila chromosomes, Flp has provided an effective methodology for F1 genetic screens (10) (11) (12) . In mammalian cell culture, Flp has been shown to effectively catalyze both excision and integration of DNA at specific chromosomal sites (13) (14) (15) (16) . By catalyzing recombination between target sites on the same DNA molecule or by promoting translocations between targets sites on different DNA molecules, site-specific recombinases can be used to study a variety of biological processes. Importantly, such recombination schemes can be used to generate tissue-or stage-specific mutations that would be lethal if generated in the whole organism.
To establish some of these methods in the mouse, it may require using both homologous (gene replacement)-and sitespecific recombination in embryonic stem (ES) cells to precisely place target sites in the genome. Consequently, the The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
properties of a given recombinase should be delineated in both ES cell culture and the mouse. While Cre-mediated recombination has been successfully employed (17) (18) (19) (20) (21) , the (24) . A variant of pFRTZ (designated pFRTZ.2) was generated by inserting the 1.9-kb XhoI/SalI fragment from pIC19R-MC1TK (25) containing the herpes simplex virus thymidine kinase (HSV-tk) gene between the FRT sequences of pFRTZ. The prototype plasmid pNEO/3-GAL (ref. 13; Stratagene) was also used as target DNA. The FLP transgene expression vector, phACTB::FLP (Fig. 1B) , was constructed by inserting the 3.9-kb XbaI/SalI fragment from pSLh3APr-lacZ-pA into the unique XbaI site of pFLP (24) . A nonexpressing, negative control FLP vector (pRevhACTB::FLP) was constructed, which contains identical hACTB sequences in reverse orientation. To generate pWntl::FLP, the 2-kb Sail fragment from pFLP, containing a synthetic intron, the sequence encoding Flp (ref. 13 ; Stratagene), and simian virus 40 early polyadenylylation (pA) sequence, was inserted into the unique EcoRV site of pWEXP2 (26) . To produce transgenic mice, transgenes were purified away from plasmid sequences and injected into fertilized eggs from B6SJLF1 x B6SJLF1 mice as described (27) .
Cell Culture. CCE ES cells (28) were plated onto mitomycin C-treated STO fibroblasts (29) in DMEM supplemented with 15% fetal bovine serum (FBS), 2 mM glutamine, 0.1 mM 2-mercaptoethanol, 2000 units/ml of leukemia inhibitory factor (ESGRO, GIBCO/BRL), 0.1 mM MEM nonessential amino acids, 30 ,tM nucleosides. Primary embryonic fibroblasts (EF) were prepared from hemizygous transgenic embryos 13.5 days post coitum as described (29) . P19 (Fig. 2) . 3-Galactosidase (3-Gal) activity was detected in situ using 5-bromo-4-chloro-3-indolyl-/3-Dgalactopyranoside (X-Gal) (30) . Primary EF cultures were plated (5 x 104 cells/ml) in 3.5-cm dishes and transfected by calcium phosphate precipitation (31) with 3 A,g of the target pFRTZ or target pNEO3-GAL (13) followed by X-Gal stain 48 hr later. P19 EC cells were plated (5 x 104 cells/ml) in 10-cm dishes. The next day, pairs of duplicate dishes were transfected by calcium phosphate precipitation (31) all-trans retinoic acid (RA; Sigma) or control diluent for an additional 5 days after which cells were stained with X-Gal.
Transcript Detection. Whole mount in situ hybridization to 9.5 days post coitum embryos was performed as described (32) using single-strand digoxigenin-UTP-labeled RNA probes. The FLP probe (antisense probe 2, Fig. 1B ) was a 1386-bp EcoRV/ApaI fragment from the 3' end of the FLP transgene; control probe (sense) was a 648-bp XbaI/EcoRV fragment. For Northern blot analyses, fresh tissue or EF cells were homogenized in 6 M guanidinium isothiocyanate and RNA isolated using acid:phenol (33) . Total cellular RNA (20 ,g) was separated and assayed for hybridization to FLP sequence as described (34) . Ethidium bromide staining of the gel and filter was used to confirm equivalent RNA loading.
Molecular Analysis of Transgenic Mouse Genotypes. Mouse tails were lysed with NaDodSO4/proteinase K and treated with phenol/chloroform, 1:1 (vol/vol), precipitated with ethanol, and dissolved in 10 mM Tris-HCL, pH 8/1 mM EDTA. For PCR analysis, DNAs were amplified with the following primers: SD42 (5'-GGTCCAACTGCAGCCCAAGCTTCC-3') and SD41 (5'-GTGGATCGATCCTACCCCTTGCG-3'), for the FLP transgene (a 0.75-kb amplified fragment); SD49 (5 '-GACTGCTCCAAAGAAGAAGCGTAAGG-3') and SD68 (5'-GCTATTACGCCAGCTGGCGAAAGG-3'), for the FRTZ transgene (a 1.4-kb amplified fragment) and FRTZproduct (a 0.25-kb fragment). The 0.25-kb PCR amplification product was cloned into plasmid pCR (TA cloning, Invitrogen) and sequenced. Genomic DNA isolated from freshly harvested tissues (35) function, a lacZ gene was disrupted by inserting an FRT cassette that contains stop codons in all three reading frames (24) . This target transgene is referred to as FRTZ, for FRTdisrupted lacZ (Fig. 1A) . Because the two FRT sequences flanking the cassette are in the same orientation, Flp activity should excise the intervening DNA leaving a single residual FRT in-frame with lacZ (Fig. 1C) . Because there are no ATG codons to initiate translation of functional p-Gal downstream of the FRT cassette, (3-Gal activity is strictly dependent on Flp-mediated excisional recombination in a manner similar to previously described 3-Gal gain-of-function systems (9, 13) .
To broadly express both FLP and FRTZ, both transgenes were placed under the control of regulatory sequences from hACTB) gene ( Fig. 1 A and B) . These hACTB sequences have been shown to be active in most tissues in transgenic mice (22) . A "recombined" control transgene, FRTZ-product, representing the predicted product of Flp recombination was also constructed (Fig. 1A) .
Flp-Mediates Efficient Recombination of Extrachromosomal DNA in ES Cells. The efficacy of Flp-mediated excisional recombination in ES cells was tested by assaying for gain of P-Gal activity following cotransfection with target and recombinase plasmids. Cells were transiently transfected with either pFRTZ plus phACTB::FLP, or pFRTZ plus the negative control plasmid pRevhACTB::FLP, followed by X-Gal stain 48 hr later. Positive control cultures were transfected with the "recombined" plasmid, pFRTZ-product ( Fig. 2A) . Cultures transfected with target plasmid pFRTZ, alone or with pRevhACTB::FLP, showed no detectable /3-Gal activity (Fig.  2B) ; in contrast, robust activity was observed following cotransfection with phACTB::FLP (Fig. 2C) .
To estimate recombinase activity, X-Gal-positive cells in each transfection were counted and compared. Fig. 3 B and D) and in adult tissues (Fig. 3 E and F) . Flp activity was assayed in EF cultures derived from each transgenic mouse line. The EF cultures were transiently transfected with target plasmid and stained with X-Gal. Maximal Flp activity (approximately 45% of the "recombined" control) was observed in lines 4917 and 4924 (Fig. 3G) , the same mouse lines that showed broad FLP expression (Fig. 3 B and D) . As shown in Fig. 3 G and H, Fig. 1 A Fig. 1A ) to allow simultaneous detection of the target FRTZ transgene and the product of recombination. As shown in Fig. 4B , the new 4.4-kb DNA fragment resulting from the recombined target was present only in samples from doubly transgenic animals, and absent in DNA isolated from either target FRTZ (Fig. 4B) 2 3 4 5 6 7 8 9 10 11 12 13 J.. .' (29) . Cultures derived from five different transgenic mouse lines (4917, 4924, 4925, 4927, 4921), and one nontransgenic line (-), were transfected with 3 pg of target pNEO,B-GAL (13) followed 48 hr later by histochemical X-Gal stain (30) . Maximal (Fig. 5 B and E) . The target plasmid alone showed no activity ( Fig. 5 A and D) . In (13) and in monkey (CV-1) and human (293) embryonic kidney cells (13, 16 Together, these findings demonstrate that Flp can serve as a tool to alter the mouse genome. By employing both Flp and Cre, it should be possible to engineer multiple independent recombination reactions (gene activation or deletion events) in mice.
